tiprankstipranks
Outlook Therapeutics (DE:41O)
NASDAQ:41O
Germany Market
41O
Outlook Therapeutics
RESEARCH TOOLSreports

Outlook Therapeutics (41O) Ratios

7 Followers

Outlook Therapeutics Ratios

DE:41O's free cash flow for Q2 2026 was $-0.17. For the 2026 fiscal year, DE:41O's free cash flow was decreased by $ and operating cash flow was $-110.07. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 0.54 0.38 0.64 0.66 1.39
Quick Ratio
 -86.01K 0.31 0.64 0.66 1.39
Cash Ratio
 0.20 0.18 0.35 0.50 0.88
Solvency Ratio
 -1.20 -1.23 -0.74 -1.26 -3.33
Operating Cash Flow Ratio
 -1.21 -1.13 -1.62 -0.92 -2.87
Short-Term Operating Cash Flow Coverage
 -2.97 -1.73 -2.34 -1.21 -5.19
Net Current Asset Value
$ -29.98T$ -33.38M$ -74.48M$ -15.76M$ 7.73M
Leverage Ratios
Debt-to-Assets Ratio
 1.24 1.62 1.03 1.10 0.38
Debt-to-Equity Ratio
 -0.94 -0.94 -0.41 -2.46 1.25
Debt-to-Capital Ratio
 -15.05 -15.15 -0.69 1.68 0.56
Long-Term Debt-to-Capital Ratio
 -0.62 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.76 -0.58 -0.39 -2.24 3.27
Debt Service Coverage Ratio
 -3.75 -2.05 -2.21 -1.55 -5.19
Interest Coverage Ratio
 -193.21 -236.86 -22.71 -34.06 -42.41
Debt to Market Cap
 0.81 0.81 0.30 0.64 0.04
Interest Debt Per Share
 0.34 0.88 1.77 2.97 1.17
Net Debt to EBITDA
 121.29K -0.35 -0.21 -0.21 0.10
Profitability Margins
Gross Profit Margin
-360.85%46.49%0.00%0.00%0.00%
EBIT Margin
-18669.97%-4505.98%0.00%0.00%0.00%
EBITDA Margin
-18634.06%-4497.70%0.00%0.00%0.00%
Operating Profit Margin
-18182.76%-4744.25%0.00%0.00%0.00%
Pretax Profit Margin
-18764.16%-4526.01%0.00%0.00%0.00%
Net Profit Margin
-18297.50%-4416.22%0.00%0.00%0.00%
Continuous Operations Profit Margin
-18297.50%-4416.22%0.00%0.00%0.00%
Net Income Per EBT
97.51%97.57%100.00%100.01%100.00%
EBT Per EBIT
103.20%95.40%105.11%111.02%104.72%
Return on Assets (ROA)
>-0.01%-335.90%-261.48%-182.61%-231.54%
Return on Equity (ROE)
<0.01%193.94%103.13%408.53%-756.04%
Return on Capital Employed (ROCE)
<0.01%246.27%522.21%368.12%-716.88%
Return on Invested Capital (ROIC)
<0.01%-2357.61%-454.96%-251.50%-319.32%
Return on Tangible Assets
>-0.01%-335.90%-261.48%-182.61%-231.54%
Earnings Yield
-102.04%-169.25%-76.09%-106.69%-25.53%
Efficiency Ratios
Receivables Turnover
 0.12 0.95 0.00 0.00 0.00
Payables Turnover
 0.11 0.07 0.01 <0.01 0.06
Inventory Turnover
 <0.01 0.23 0.00 0.00 0.00
Fixed Asset Turnover
 1.67 6.27 0.00 0.00 0.00
Asset Turnover
 0.02 0.08 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.01 -0.06 0.00 0.00 0.00
Cash Conversion Cycle
 779.62M -2.92K -25.55K -54.31K -6.23K
Days of Sales Outstanding
 2.98K 384.99 0.00 0.00 0.00
Days of Inventory Outstanding
 779.62M 1.61K 0.00 0.00 0.00
Days of Payables Outstanding
 3.18K 4.92K 25.55K 54.31K 6.23K
Operating Cycle
 779.62M 2.00K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.57 -1.49 -3.71 -3.44 -5.34
Free Cash Flow Per Share
 -0.57 -1.49 -3.71 -3.44 -5.34
CapEx Per Share
 0.00 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -17.28M 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 0.00 -17.28M 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -1.73 -1.72 -2.31 -1.21 -5.17
Operating Cash Flow to Sales Ratio
 -141.22 -36.67 0.00 0.00 0.00
Free Cash Flow Yield
-75808528.57%-140521023.34%-69.45%-77.73%-21.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.09 -0.59 -1.31 -0.94 -3.92
Price-to-Sales (P/S) Ratio
 100.00 26.09 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 -2.29 -1.15 -1.36 -3.83 29.62
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.71 -0.71 -1.44 -1.29 -4.57
Price-to-Operating Cash Flow Ratio
 -1.41 -0.71 -1.44 -1.29 -4.57
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.01 0.09 0.04 0.37
Price-to-Fair Value
 -2.29 -1.15 -1.36 -3.83 29.62
Enterprise Value Multiple
 -0.85 -0.93 -1.58 -1.18 -3.92
Enterprise Value
 -7.53T 59.00M 113.86M 67.45M 252.30M
EV to EBITDA
 121.29K -0.93 -1.58 -1.18 -3.92
EV to Sales
 -22.60M 41.74 0.00 0.00 0.00
EV to Free Cash Flow
 0.33 >-0.01 -1.66 -1.57 -4.45
EV to Operating Cash Flow
 0.33 >-0.01 -1.66 -1.57 -4.45
Tangible Book Value Per Share
 -0.35 -0.93 -3.94 -1.15 0.82
Shareholders’ Equity Per Share
 -0.35 -0.93 -3.94 -1.15 0.82
Tax and Other Ratios
Effective Tax Rate
 0.02 0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
 <0.01 0.04 0.00 0.00 0.00
Net Income Per Share
 -0.74 -1.79 -4.06 -4.72 -6.23
Tax Burden
 0.98 0.98 1.00 1.00 1.00
Interest Burden
 1.01 1.00 1.04 1.03 1.02
Research & Development to Revenue
 63.78 19.23M 0.00 0.00 0.00
SG&A to Revenue
 114.35 28.25 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 4.92M 6.29M 0.00 0.00 0.00
Income Quality
 0.83 0.83 0.91 0.73 0.86
Currency in USD